The Proceedings of the American Thoracic Society 2:403-411 (2005)
© 2005 The American Thoracic Society
Innate Immunity in the Lungs
Thomas R. Martin and
Charles W. Frevert
Medical Research Service, VA Puget Sound Health Care System; and Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, Washington
Correspondence and requests for reprints should be addressed to Thomas R. Martin, M.D., Pulmonary Research Laboratories, VA Puget Sound Health Care System, 151L, 1660 South Columbian Way, Seattle, WA 98108. E-mail: trmartin{at}u.washington.edu
ABSTRACT
Innate immunity is a primordial system that has a primary role in lung antimicrobial defenses. Recent advances in understanding the recognition systems by which cells of the innate immune system recognize and respond to microbial products have revolutionized the understanding of host defenses in the lungs and other tissues. The innate immune system includes lung leukocytes and also epithelial cells lining the alveolar surface and the conducting airways. The innate immune system drives adaptive immunity in the lungs and has important interactions with other systems, including apoptosis pathways and signaling pathways induced by mechanical stretch. Human diversity in innate immune responses could explain some of the variability seen in the responses of patients to bacterial, fungal, and viral infections in the lungs. New strategies to modify innate immune responses could be useful in limiting the adverse consequences of some inflammatory reactions in the lungs.
Key Words: endotoxin innate immunity lung inflammation Toll-like receptors
This article has been cited by other articles:

|
 |

|
 |
 
P-R. Burgel and J. A. Nadel
Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases
Eur. Respir. J.,
October 1, 2008;
32(4):
1068 - 1081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. H. Chen, Tae Jin Kang, A. K. Bhattacharjee, and A. S. Cross
Intranasal administration of a detoxified endotoxin vaccine protects mice against heterologous Gram-negative bacterial pneumonia
Innate Immunity,
October 1, 2008;
14(5):
269 - 278.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Clement, S. E. Evans, C. M. Evans, D. Hawke, R. Kobayashi, P. R. Reynolds, S. J. Moghaddam, B. L. Scott, E. Melicoff, R. Adachi, et al.
Stimulation of Lung Innate Immunity Protects against Lethal Pneumococcal Pneumonia in Mice
Am. J. Respir. Crit. Care Med.,
June 15, 2008;
177(12):
1322 - 1330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Martin
Interactions between Mechanical and Biological Processes in Acute Lung Injury
Proceedings of the ATS,
April 15, 2008;
5(3):
291 - 296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Buckley, W. Shi, L. Barsky, and D. Warburton
TGF-{beta} signaling promotes survival and repair in rat alveolar epithelial type 2 cells during recovery after hyperoxic injury
Am J Physiol Lung Cell Mol Physiol,
April 1, 2008;
294(4):
L739 - L748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Kelly, K. McNagny, D. L. Williams, N. van Rooijen, L. Maxwell, C. Gwozd, C. H. Mody, and P. Kubes
The Lung Responds to Zymosan in a Unique Manner Independent of Toll-Like Receptors, Complement, and Dectin-1
Am. J. Respir. Cell Mol. Biol.,
February 1, 2008;
38(2):
227 - 238.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Landsman and S. Jung
Lung Macrophages Serve as Obligatory Intermediate between Blood Monocytes and Alveolar Macrophages
J. Immunol.,
September 15, 2007;
179(6):
3488 - 3494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Blank, B. Rothen-Rutishauser, and P. Gehr
Dendritic Cells and Macrophages Form a Transepithelial Network against Foreign Particulate Antigens
Am. J. Respir. Cell Mol. Biol.,
June 1, 2007;
36(6):
669 - 677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Jeyaseelan, S. K. Young, M. B. Fessler, Y. Liu, K. C. Malcolm, M. Yamamoto, S. Akira, and G. S. Worthen
Toll/IL-1 Receptor Domain-Containing Adaptor Inducing IFN-beta (TRIF)-Mediated Signaling Contributes to Innate Immune Responses in the Lung during Escherichia coli Pneumonia
J. Immunol.,
March 1, 2007;
178(5):
3153 - 3160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Livraghi and S. H. Randell
Cystic Fibrosis and Other Respiratory Diseases of Impaired Mucus Clearance
Toxicol Pathol,
January 1, 2007;
35(1):
116 - 129.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Thoracic Society.
|
|
|